Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2017-01-09

FDA Approved: NEXIUM 24HR CLEARMINIS — Supplemental Application (Haleon US Holdings LLC)

View source ↗

Summary

FDA approved a supplemental application to add NEXIUM 24HR CLEARMINIS (esomeprazole magnesium) to Haleon US Holdings LLC's Nexium product lineup.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • NEXIUM 24HR CLEARMINIS (Esomeprazole magnesium)

Snippet

SUPPL AP for NEXIUM 24HR CLEARMINIS (ESOMEPRAZOLE MAGNESIUM)